학술논문
A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer
Document Type
Article
Author
Source
In Lung Cancer July 2021 157:21-29
Subject
Language
ISSN
0169-5002